Anticompetitive Drug Rebates May Need FTC Rulemaking For Timely Reform, Commissioners Say
Executive Summary
‘Rebate walls’ report heads to US Congress, but Democratic commissioners suggest FTC’s typical approach to curtailing such practices is too time consuming.